Demographics 360 - online access to ....…
Our online database provides detailed epidemiology, health expenditure, demographic and socio-economic forecasts from which to make market and investment decisions. It covers:
101 different diseases
75 countries: 31 China Provinces: 625 China Cities
Providing historic data from: 2005 to 2015, Forecasts to 2036.
Choose a country, China Province or City - then explore using either the preset tables, interactive apps to change the forecast for a variable(s) and see the impact onother variables, or create custom tables for download and analysis.
Quickly see how much a country spends in total on healthcare, what proportion is government funded and how much is private.
Easily compare countries in terms of how much is spent per capita and per chronic condition.
How is healthcare funded and how this might change over the next two decades.
Incidence and Prevalence
Compare countries in terms of historic and projected incidence of 6 cancers and prevalence of 6 chronic conditions.
How Healthy are these countries and what is the trend,
Understand how the underlying population profile will change in the future. See the extent to which different age groups are expected to change in size over selected years; total population growth; trend in births and deaths; trend in the birth rate, etc.
Household Income & Expenditure
What is the real average household income?
How will it change over a selected time period?
By income segment, see what proportion of it is spent .. and how much on each of 12 expenditure categories?
Education & Productivity
See how the education profile of the adult population has and will change over time.
Examine the impact education and fixed capital investment have on productivity and the implication for wages and household incomes.
How will the number of households & their distribution by number of occupants change over time?
What is the implication in terms of housing requirements?
How much will the size of the working age population change in future? What is the impact of the older worker?
How will a changing working age population and propensity to work affect the future size of the labour force and GDP?
Interactive Epidemiology models
Basic version Enables you to see forecasts of the number of cases as well as incidence/prevalence rate for selected age/gender segments by country/Province/City. Advanced version provides a forecast of the prpoption of the affected population who can afford a treatment at a specific (ser defined) price and under a user defined funding scenario.
The model lets you test a range of scenarios for any country, China Province or China City.
$120/month - for all 75 Countries & 32 Provinces of China
$120/month - For all the largest 100 China Cities
$120/month - For all the remaining 525 China Cities
Interactive Models are an additional charge
Try the Demo or Subscribe:
Our Value Add
Good business decisions depend on understanding how the business environment is changing. Global Demographics Healthcare's online database and apps provide forecasts and insights of what the future demand will be for health care services. This includes number of cases by age and gender, affordability, levels of expenditure by households as well as by governments and how that expenditure is funded.
How affordable is a new cancer treatment? To read our report on this please click here:
Just need the data? The database for each country (including forecasts) is available in Excel format for immediate download once payment is received by credit card. The price per country, China Province or China City is US$150.
For details on the variables included in the database please go to the page on Databases.
Interactive Epidemiology Models
The Epidemiology Models apply forecast trends in Epidemiology data to the demographic forecasts (age by gender by income) to provide detailed estimates of the number of cases for each of a range of diseases. As the forecasts are done by 5 year age groups and by gender the detail is quite high. They also provide estimates of the number of persons with the disease who can afford treatment given a specific price and funding scenario.